Progenity: Surbhi Sarna

Progenity has appointed Surbhi Sarna to its board of directors effective July 1. She is currently a visiting partner at Y Combinator. Sarna founded nVision Medical and acted as CEO of the medical device company until it was acquired by Boston Scientific in 2018, where she led commercial efforts for nVision until 2020. She previously served in healthcare engineering roles at BioCardia and Abbott Vascular.

Sarna is a board member at medical device company Penumbra and on its audit and nominating and corporate governance committees. She's also on the board of trustees at Astia, which provides access to capital and networks to women entrepreneurs.